Latest News in the pharma Industry

All

Charles River Laboratories acquires Brains On-Line

Charles River Laboratories acquires Brains On-Line

23 Aug 2017

Establishes Charles River as a premier source for CNS contract research services.

Read more 
Novavax’ preclinical influenza nanoparticle study published in Vaccine

Novavax’ preclinical influenza nanoparticle study published in Vaccine

23 Aug 2017

Data suggest that NanoFlu has the potential to elicit a broader, more robust immune response, resulting in greater protection than the market-leading licensed influenza vaccine in older adults.

Read more 
Novartis and MMV launch patient trial in Africa for a novel compound against multidrug-resistant malaria

Novartis and MMV launch patient trial in Africa for a novel compound against multidrug-resistant malaria

23 Aug 2017

Compound has potential to be a game-changer in malaria elimination, rapidly clearing malaria infection, including resistant strains, and blocking parasite transmission.

Read more 
Bavarian Nordic closes transaction with Janssen Pharmaceuticals

Bavarian Nordic closes transaction with Janssen Pharmaceuticals

22 Aug 2017

Collaboration grants Janssen the exclusive rights to Bavarian Nordic’s MVA-BN technology for two additional programs, targeting vaccines against hepatitis B virus and the human immunodeficiency virus.

Read more 
Amgen and Humana partner for improved health outcomes and efficiency

Amgen and Humana partner for improved health outcomes and efficiency

22 Aug 2017

Partnership to target multiple serious diseases using real world data studies.

Read more 
Spray drying specialist to invest €19 million in GMP facility expansion

Spray drying specialist to invest €19 million in GMP facility expansion

22 Aug 2017

Investment is in response to increased market for spray drying and capsule filling for dry powder inhalers.

Read more 
Oak Therapeutics completes critical milestone in Phase I to develop oral dissolvable strip for TB

Oak Therapeutics completes critical milestone in Phase I to develop oral dissolvable strip for TB

22 Aug 2017

Comapny has created a novel formulation to produce a product prototype containing 300 mg of Isoniazid, that is both rapidly dissolving and mucoadhesive.

Read more 
Oxford Genetics secures £7.5 million investment

Oxford Genetics secures £7.5 million investment

21 Aug 2017

Investment will fund a new office in Boston, US, an extension of its UK facility at the Oxford Science Park, and R&D capabilities to increase its intellectual property portfolio.

Read more 
Champions Oncology collaborates with AstraZeneca to develop unique cohorts of PDX models

Champions Oncology collaborates with AstraZeneca to develop unique cohorts of PDX models

21 Aug 2017

Models will be used in AstraZeneca's oncology R&D programs in breast and lung cancer.

Read more 
RedHill Biopharma announces US commercialization agreement for FDA-approved GI product

RedHill Biopharma announces US commercialization agreement for FDA-approved GI product

21 Aug 2017

Esomeprazole Strontium DR capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor, indicated for adults for the treatment of gastroesophageal reflux disease and other gastrointestinal conditions.

Read more 
BMS and Pfizer to highlight commitment to reducing the risk of stroke at ECS Congress 2017

BMS and Pfizer to highlight commitment to reducing the risk of stroke at ECS Congress 2017

20 Aug 2017

Eliquis clinical data include results from a Phase IV trial to be featured in late-breaking science sessions,

Read more 
A plant-based delivery system for anti-cancer drugs

A plant-based delivery system for anti-cancer drugs

20 Aug 2017

Study demonstrates that a complex consisting of tobacco mosaic virus and vcMMAE can kill cancer cells.

Read more